Evidence map›Paper›PMID 40498485›Full record

ArticleJAMA network open2025

Resistance Training and Lymphedema in Breast Cancer Survivors.

Parisa Shamsesfandabadi, Mostafa Shams Esfand Abadi, Yue Yin, David J Carpenter, Chris Peluso, Christie Hilton, Suzanne B Coopey, Janette Gomez, Sushil Beriwal, Colin E Champ

Registry-linked trialAbstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07448467 (Investigating the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema Developing After Breast Cancer Treatment), which is not on this map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07448467 nacompletednot on this mapstarted 2026, after this paper: background citation

Investigating the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema Developing After Breast Cancer Treatment: a Randomized Controlled Trial

TypeinterventionalSponsorUskudar UniversityRan2026 to 2026Enrolled50ConditionsLymphedema, Breast CancerArmscontrol, exercise
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Parisa ShamsesfandabadiDepartment of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.
Mostafa Shams Esfand AbadiDepartment of Statistical Sciences, Wake Forest University, Winston-Salem, North Carolina.
Yue YinAllegheny-Singer Research Institute, Allegheny Health Network, Pittsburgh, Pennsylvania.
David J CarpenterDepartment of Radiation Oncology, Wellstar Paulding Medical Center, Hiram, Georgia.
Chris PelusoAllegheny Health Network Cancer Institute Exercise Oncology and Resiliency Center, Pittsburgh, Pennsylvania.
Christie HiltonDepartment of Medical Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.
Suzanne B CoopeyDepartment of Surgery, Allegheny Health Network, Pittsburgh, Pennsylvania.
Janette GomezDepartment of Surgery, Allegheny Health Network, Pittsburgh, Pennsylvania.
Sushil BeriwalDepartment of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.
Colin E ChampDepartment of Radiation Oncology, Allegheny Health Network, Pittsburgh, Pennsylvania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Lymphedema is a common treatment-related adverse effect among breast cancer survivors that can limit activity and mobility. Although exercise is associated with improved outcomes after breast cancer treatment, data are limited on the association of intense physical activity, including strength training, with lymphedema. Objective: To examine the association between resistance training and lymphedema among breast cancer survivors. Design, Setting, and Participants: In this cohort study conducted between September 15, 2022, and March 26, 2024, women from 3 prospective studies (EXERT-BC, EXERT-BCN, and EXERT-C) underwent thrice-weekly, dose-escalated resistance training for 3 months to promote strength, mobility, and hypertrophy. Main Outcomes and Measures: Lymphedema was assessed at baseline and completion using bioimpedance analysis to evaluate fluid and body composition metrics, distinguishing among intracellular water, extracellular water, and total body water. Results: A total of 115 women completed the exercise regimen (median age, 54 years; range, 24-71 years). Ninety-six participants (83%) underwent sentinel lymph node biopsy, whereas 14 (12%) underwent axillary lymph node dissection. At baseline, 15 women (13%) had clinical lymphedema: 8 (8%) in the sentinel lymph node biopsy group and 7 (37%) in the axillary lymph node dissection group. No participants experienced subjective or clinical worsening of lymphedema after completing the exercise regimen. Bilateral arm lean mass significantly increased after resistance training (affected arm: median [IQR], 5.64 [4.98-6.20] lb; 95% CI, 5.40-5.84 lb) vs baseline (median [IQR], 5.45 [4.92-6.08] lb; 95% CI, 5.34-5.67 lb) (s = 1789.5; P < .001). The edema index (extracellular water to total body water ratio) significantly improved in all patients, signifying a reduction in lymphedema at the completion of exercise (mean, 0.383; 95% CI, 0.382-0.385) compared with baseline (mean, 0.385; 95% CI, 0.384-0.386) (t110 = 4.05; P < .001). CONCLUSIONS AND RELEVANCE: In this cohort study of breast cancer survivors, intense resistance training did not exacerbate lymphedema and was associated with improvements in fluid balance and lean mass in the upper extremities. These findings suggest support for the inclusion of structured resistance exercise as part of breast cancer treatment and survivorship care.

Indexed as

Breast NeoplasmsCancer SurvivorsLymphedemaResistance TrainingAdultAgedFemaleHumansMiddle AgedProspective StudiesYoung Adult

Identifiers

PMID40498485
PMCPMC12159776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.